Claire Barton

4.1k citations
40 papers · 2.7k · 1 hit paper · h-index 19

Impact in

  • Oncology top 1%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Peptidase Inhibition and Analysis
    • Pancreatic and Hepatic Oncology Research
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

    • HER2/EGFR in Cancer Research 11
    • Cancer Treatment and Pharmacology 9
    • Pancreatic and Hepatic Oncology Research 5
    • Peptidase Inhibition and Analysis 3
    • Cancer Genomics and Diagnostics 4
    • Breast Cancer Treatment Studies 4

Claire Barton

38 papers receiving 2.7k citations

Hit Papers

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort 2010 · 891 citations
8910+5+10Years since publication250500750

Peers

Claire Barton
Comparison fields: 5 of 89
  • Oncology 2.0k
  • Cancer Research 828
  • Radiology, Nuclear Medicine and Imaging 689
  • Pulmonary and Respiratory Medicine 519
  • Pathology and Forensic Medicine 194
Replace Marta Guix with:
Marta Guix Spain
Yun Gong United States
Vincenzo Damiano Italy
Volker Möbus Germany
Cammie Rinehart United States
John C. Araujo United States
G. Deplanque France
Nancy T. Sklarin United States
Vassiliki Kotoula Greece
Fabiana Tatangelo Italy
Claire Barton relative to Marta Guix Spain Marta Guix's profile →
Citations per field
00.5×1.7×
Marta Guix · 1×
Citations per year

Countries citing papers authored by Claire Barton

Since Specialization
Citations

This map shows the geographic impact of Claire Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Barton more than expected).

Fields of papers citing papers by Claire Barton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Barton. The network helps show where Claire Barton may publish in the future.

Co-authors

The 25 scholars most cited alongside Claire Barton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Claire Barton Line = papers co-authored together Claire Barton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Hit paper breakdown →
2010891
2 2005306
3 2003298
4 1991163
5 1992153
6 1991138
7 2003115
8 200994
9 200983
10 199272
11 199045
12 199343
13 201640
14 202031
15 199530
16 199328
17 200024
18 199023
19 201819
20 199017

About Claire Barton

Claire Barton is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 40 papers that have together received 2.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Cancer Treatment and Pharmacology (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Breast Cancer Treatment Studies (4 papers), Peptidase Inhibition and Analysis (3 papers) and Urinary and Genital Oncology Studies (2 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (828 citations), Radiology, Nuclear Medicine and Imaging (689 citations), Pulmonary and Respiratory Medicine (519 citations) and Pathology and Forensic Medicine (194 citations). Claire Barton has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Nicholas R. Lemoine, Parviz Ghahramani, Christine M. Hughes, William J. Gullick, Luca Gianni, José Baselga, Peter A. Hall, W. Eiermann, Miguel Ángel Climent and Mauro Mansutti. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Molecular Carcinogenesis, European Journal of Cancer and The Journal of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact